| The tuberculosis drug streptomycin as a potential cancer therapeutic: inhibition of miR‐21 function by directly targeting its precursor D Bose, G Jayaraj, H Suryawanshi, P Agarwala, SK Pore, R Banerjee, ... Angewandte Chemie-International Edition 51 (4), 1019, 2012 | 197 | 2012 |
| High-throughput sequence analysis reveals structural diversity and improved potency among RNA inhibitors of HIV reverse transcriptase MA Ditzler, MJ Lange, D Bose, CA Bottoms, KF Virkler, AW Sawyer, ... Nucleic acids research 41 (3), 1873-1884, 2013 | 69 | 2013 |
| An RNA-based fluorescent biosensor for high-throughput analysis of the cGAS-cGAMP-STING pathway D Bose, Y Su, A Marcus, DH Raulet, MC Hammond Cell chemical biology 23 (12), 1539-1549, 2016 | 66 | 2016 |
| A molecular-beacon-based screen for small molecule inhibitors of miRNA maturation D Bose, GG Jayaraj, S Kumar, S Maiti ACS chemical biology 8 (5), 930-938, 2013 | 60 | 2013 |
| Selective inhibition of miR-21 by phage display screened peptide D Bose, S Nahar, MK Rai, A Ray, K Chakraborty, S Maiti Nucleic acids research 43 (8), 4342-4352, 2015 | 55 | 2015 |
| Broad-spectrum aptamer inhibitors of HIV reverse transcriptase closely mimic natural substrates MA Ditzler, D Bose, N Shkriabai, B Marchand, SG Sarafianos, ... Nucleic acids research 39 (18), 8237-8247, 2011 | 52 | 2011 |
| cGAS/STING pathway in cancer: Jekyll and Hyde story of cancer immune response D Bose International Journal of Molecular Sciences 18 (11), 2456, 2017 | 49 | 2017 |
| RNA editing: Expanding the potential of RNA therapeutics BJ Booth, S Nourreddine, D Katrekar, Y Savva, D Bose, TJ Long, DJ Huss, ... Molecular Therapy 31 (6), 1533-1549, 2023 | 22 | 2023 |
| Anti-cancer therapeutic potential of quinazoline based small molecules via global upregulation of miRNAs SK Panja Chemical communications 50 (35), 4639-4642, 2014 | 22 | 2014 |
| Dynamic regulation of tRNA modifications in cancer P Close, D Bose, A Chariot, SA Leidel Cancer and noncoding RNAs, 163-186, 2018 | 13 | 2018 |
| Specificity of RSG-1.2 peptide binding to RRE-IIB RNA element of HIV-1 over Rev peptide is mainly enthalpic in origin S Kumar, D Bose, H Suryawanshi, H Sabharwal, K Mapa, S Maiti PLoS One 6 (8), e23300, 2011 | 11 | 2011 |
| Differential interleukin-2 transcription kinetics render mouse but not human T cells vulnerable to splicing inhibition early after activation D Bose, A Neumann, B Timmermann, S Meinke, F Heyd Molecular and Cellular Biology 39 (16), e00035-19, 2019 | 7 | 2019 |
| Cyclic cationic peptides containing sugar amino acids selectively distinguishes and inhibits maturation of pre-miRNAs of the same family S Nahar, D Bose, S Pal, TK Chakraborty, S Maiti nucleic acid therapeutics 25 (6), 323-329, 2015 | 4 | 2015 |
| RNA-Editing Compositions and Methods of Use Y Savva, R Sullivan, B Booth, A Briggs, D Bose, S Byrne, S Burleigh US Patent App. 18/036,176, 2023 | | 2023 |
| Compositions and Methods for Modifying Target RNAs A Briggs, B Booth, D Bose, D Huss, Y SAVVA, R Sullivan US Patent App. 17/925,871, 2023 | | 2023 |
| Compositions and Methods for Genome Editing D Bose US Patent App. 17/925,870, 2023 | | 2023 |
| rna editing compositions and uses thereof D BOSE, R Sullivan, B Booth, Y SAVVA, A Briggs, S BYRNE, ... WO Patent App. WO2022103839A1, 2022 | | 2022 |
| Rna-editing compositions and methods of use Y SAVVA, R Sullivan, B Booth, A Briggs, D BOSE, S BYRNE, ... WO Patent App. CA3174139A1, 2022 | | 2022 |
| Compositions and methods for modifying target rnas A Briggs, B Booth, D BOSE, D HUSS, Y SAVVA, R Sullivan WO Patent App. CA3,177,380 A, 2021 | | 2021 |
| Compositions and methods for genome editing D Bose WO Patent WO 2021/242870 A1, 2021 | | 2021 |
Souvik MaitiInstitute of Genomics and Integrative BiologyVerified email at igib.res.in
